COMPARISON OF LABETALOL VERSUS LIDOCAINE IN ATTENUATION OF HEMODYNAMIC RESPONSE DURING LARYNGOSCOPY AND ENDOTRACHEAL INTUBATION
Main Article Content
Keywords
Hemodynamic Response, Labetalol, Lidocaine, Laryngoscopy, Endotracheal intubation
Abstract
Objective: To compare labetalol versus lidocaine in attenuation of hemodynamic response during laryngoscopy and endotracheal intubation.
Background: Endotracheal intubation and laryngoscopy are unpleasant stimuli that cause sympathomimetic reactions. Even though it's widely tolerated in healthy individuals, there could be potentially fatal consequences. Although lignocaine and benetacol reduce these reactions, they are linked to hypotension and bradycardia adverse effects.
Study design: A Randomized controlled trial
Place and Duration: This study was conducted in Liaquat University of Medical and Health Sciences Jamshoro from March 2023 to March 2024
Methodology: All patients aged 20-60 years of either gender scheduled for various general surgical procedures under endotracheal anesthesia having ASA status I & II were consecutively enrolled. Two groups LG (lignocaine group) and LB (Labetalol group) was made. Hemodynamic responses in terms of systolic blood pressure (SBP) and mean arterial pressure (MAP) was noted during laryngoscopy and 10 mins after endotracheal intubation.
Results: Out of 62 patients, Mean SBP after laryngoscopy was significantly higher among patients who were in Lignocaine group than in Labetalol group, i.e., 127.48 ±2.54 vs. 122.13 ±2.67 (p-value <0.001, 95% CI 4.03-6.68). Mean MAP after laryngoscopy was significantly higher among patients who were in Lignocaine group than in Labetalol group, i.e., 104.74 ±3.51 vs. 92.29 ±4.42 (p-value <0.001, 95% CI 10.42-14.48).
Conclusion: A significant difference in attenuation of hemodynamic response was observed in between labetalol versus lidocaine use during laryngoscopy and endotracheal intubation.
References
2. Stoelting RK. Circulatory changes during direct laryngoscopy and tracheal intubation: Influence of duration of laryngoscopy with or without prior lidocaine.Anesthesiology.1977;47:381–4.
3. Fox EJ, Sklar GS, Hill CH, Villanueva R, King BD. Complications related to pressor response to endotracheal intubation. Anaesthesiol. 1977;47:524-5
4. Prys-Roberts C, Foëx P, Biro GP, Roberts JG. Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade. Br J Anaesth.1973;45:671–81.
5. Kumar A, Mishra PK, Shukla S. A randomized, controlled study to compare the effects of intravenous labetalol and esmolol on haemodynamic changes during laryngoscopy and intubation. Int J Res Med Sci. 2017;5:4003-7.
6. Chung KS, Sinatra RS, Chung JH. The effect of an intermediate dose of labetalol on heart rate and blood pressure response to laryngoscopy and intubation. J Clin Anesth. 1992;4:11-5
7. Laurito CE, Baughman VL, Becker GL, Polek WV, Riegler FX, VadeBoncouer TR. Effects of aerosolized and/or intravenous lidocaine on hemodynamic responses to laryngoscopy and intubation in outpatients. Anesth Analg.1988;67:389–92.
8. El-Shmaa NS, El-Baradey GF. The efficacy of labetalol vs dexmedetomidine for attenuation of hemodynamic stress response to laryngoscopy and endotracheal intubation. Journal of clinical anesthesia. 2016 Jun 1;31:267-73.
9. Leslie JB, Kalayjian RW, McLoughlin TM, Plachetka JR. Attenuation of the hemodynamic responses to endotracheal intubation with preinduction intravenous labetalol. Journal of clinical anesthesia. 1989 Jan 1;1(3):194-200.
10. Ratnani E, Sanjeev OP, Singh A, Tripathi M, Chourasia HK. A comparative study of intravenous esmolol, labetalol and lignocaine in low doses for attenuation of sympathomimetic responses to laryngoscopy and endotracheal intubation. Anesth Essays Res. 2017;11(3):745-50.
11. Kaladhar S, Korukonda V. Attenuation of haemodynamic response to laryngoscopy and endotracheal intubation a comparative study between I.V. labetalol and I.V. lignocaine. Indian J Clin Anaes. 2020;7(4):676-80.
12. Jaiswal A, Pawar D, Bhople P. Attenuation of pressor response by intravenous labetalol and its comparison with intravenous lignocaine. Paripex Indian J Res. 2017;6(7):